Orchid Pharmed
Orchid Pharmed is a Tehran-based pharmaceutical marketing company that commercializes biologic drugs on behalf of partner manufacturers through a 700+ person field force covering 60+ Iranian cities, with adjacent clinical research and patient support capabilities.
- Company typePrivate
- Founded2014
- HeadquartersTehran, Iran
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Orchid Pharmed does
Orchid Pharmed is an Iranian pharmaceutical marketing and distribution company founded in 2014, headquartered in Tehran. The company operates as a contract sales and marketing organization, commercializing biologic drugs and pharmaceutical products on behalf of partner manufacturers in Iran's regulated healthcare market. With over 700 employees and coverage across more than 60 Iranian cities, Orchid Pharmed has built a national field force focused on healthcare professional engagement, clinical evidence generation, and patient support.
Orchid Pharmed firmographics
Firmographics- Name
- Orchid Pharmed
- Legal name
- Orchid Pharmed
- Website
- https://orchidpharmed.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Orchid Pharmed is a Tehran-based pharmaceutical marketing company that commercializes biologic drugs on behalf of partner manufacturers through a 700+ person field force covering 60+ Iranian cities, with adjacent clinical research and patient support capabilities.
- Ownership category
- akta.pro rank
Orchid Pharmed industry classification
Industry- Product category
- Pharmaceutical Marketing Services
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
- akta.pro secondary industries
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Pharmacovigilance & Drug Safety Software (HLAGAJAK)
Keywords
Where Orchid Pharmed is headquartered
LocationHeadquarters
- HQ city
- Tehran
- HQ country
- Iran
- HQ region
- Middle East
Offices1 record
Markets served
Orchid Pharmed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Product Marketing: OrchidPharmed markets advanced biologic drugs and pharmaceutical products for partner manufacturers. The company supports product commercialization, market positioning, and sales across Iran's pharmaceutical market. Revenue is generated through marketing services and product distribution support.
- Clinical Research Services: The company conducts clinical studies and trials for pharmaceutical manufacturers, contributing to product development and regulatory approval processes. This includes registering studies in the Iranian Clinical Trials Registry and adhering to international standards.
- Patient Support Services: OrchidLife division provides ongoing patient education, medication training, and support services that enhance medication adherence and treatment outcomes for covered products.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Orchid Pharmed product offering
Product offeringCore offering
Orchid Pharmed is a pharmaceutical marketing and services company that commercializes biologic drugs and pharmaceutical products on behalf of partner manufacturers in Iran. It provides contracted marketing, sales, branding, supply chain, and market access services, runs clinical trials and pharmacovigilance programs, and operates the OrchidLife patient support division with 24/7 assistance and medication training centers in 60+ cities.
Product overview
OrchidPharmed is a pioneering Iranian pharmaceutical company founded in 2014 that operates as a pharmaceutical marketing and services organization. The company offers a comprehensive portfolio centered around biologic drug marketing, clinical research services, and patient support programs. Its core Product Service Division handles marketing, sales, branding, and supply chain operations, while the OrchidLife sub-brand provides extensive patient education and 24/7 support services. The Science division delivers clinical trials, pharmacovigilance, and health data science capabilities. Business Architecture and Information Technology divisions support data-driven decision-making. Together, these divisions enable nationwide medication accessibility and advanced pharmaceutical marketing across Iran.
Differentiator
Problem solved
Functional benefit
Brands
- OrchidLife: Division dedicated to providing 24/7 patient support, medication training, and MS awareness. Operates in 60 cities with over 60 free training centers across Iran.
- OrchidLife's MS Page
Products and services
- Pharmaceutical Marketing and Sales (Product Service Division) Contracted marketing, sales, branding, supply chain, pipeline development, and market access services for biologic and pharmaceutical products on behalf of partner manufacturers in Iran. Supports product support for new drugs each year (2 in 2015, growing to 30 new drugs in 2022).
- OrchidLife Patient Support Services Patient support division providing 24/7 consumer assistance, online physician education, and medication training through 60+ free centers nationwide. Includes a dedicated MS patient support page and supports patients across 60 cities in Iran.
- Clinical Research Services Clinical study design, ethical compliance, registration with the Iranian Clinical Trials Registry, and execution of clinical trials to international standards. Ranked #1 in clinical studies in Iran.
- Pharmacovigilance Services Drug safety monitoring through adverse event reporting, causality assessment, signal detection, and risk evaluation for consumer safety and treatment optimization.
- Health Data Science Services Data science unit that establishes sample sizes and randomization methods for clinical studies, analyzes and collects data, and designs clinical study protocols.
- Supply Chain and Market Access Services National supply chain and distribution coordination across 60+ cities in Iran, ensuring product availability across all sales touchpoints and supporting daily operations across departments and geographic regions.
Quantifiable outcome
- Ranked first in clinical studies in Iran
- +4 more outcomes
Companies that use Orchid Pharmed
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Orchid Pharmed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Orchid Pharmed partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- InocloncorePharmaceutical company partner featured in OrchidPharmed's business partners section. Inoclon collaborates with OrchidPharmed for product marketing and distribution services in the Iranian pharmaceutical market.
- ArnogencorePharmaceutical company partner of OrchidPharmed. Arnogen works with OrchidPharmed for product commercialization and market access support.
- NanoalvandcoreNanotechnology pharmaceutical company partner. Nanoalvand collaborates with OrchidPharmed for marketing and distribution of nano-pharmaceutical products.
- CinnagencorePharmaceutical company partner providing biologic drugs for the Iranian market. Cinnagen partners with OrchidPharmed for product marketing and market expansion.
- Arvand PharmedcorePharmaceutical partner collaborating with OrchidPharmed for product distribution and brand development services.
- Alasht PharmedcorePharmaceutical company partner of OrchidPharmed for market access and sales support in Iran.
- EspadcorePharmaceutical partner working with OrchidPharmed for product marketing and distribution services.
Scale indicators7 records
Recent moves6 records
Expansion highlights4 records
Orchid Pharmed competitors and assessment
Company assessmentOthers
- Veeva Systems: Cloud software provider for pharma commercial operations, including CRM, medical affairs, and pharmacovigilance. Adjacent enabling technology that powers the kind of commercial and safety infrastructure OrchidPharmed has built in-house, making it a comparable technology and business model reference point.
Direct peers
- IQVIA: Global leader in healthcare commercial services, including contract sales, market access, real-world evidence, and clinical research for pharma manufacturers. Directly comparable in business model to OrchidPharmed's integrated marketing, sales, and clinical services platform, though at vastly larger scale and geographic reach.
- CMIC Holdings: Japan-based CRO and pharma services group offering clinical development, commercial services, and market entry support. Comparable vertically integrated pharma services business model operating in a single dominant geography, similar to OrchidPharmed's Iran focus.
- Inizio: Specialist pharma services platform spanning commercialization, market access, and patient solutions. Highly comparable to OrchidPharmed's end-to-end commercialization model for biologic and specialty drug manufacturers.
- Syneos Health: Biopharmaceutical services organization providing both clinical development and commercial solutions including contract sales, medical affairs, and patient engagement. Closely aligned with OrchidPharmed's combined clinical + commercial + patient support offering for pharma manufacturers.
- Apodi (Cencora): Pharma services business of Cencora (formerly AmerisourceBergen) providing outsourced sales, marketing, and distribution support to manufacturers. Directly parallels OrchidPharmed's outsourced commercialization and supply chain model for specialty pharmaceuticals.
Broad incumbents
- Charles River Laboratories: Global CRO and preclinical services provider. Partial overlap with OrchidPharmed's clinical research services and pharmacovigilance, though focused on earlier-stage research rather than commercialization.
- Parexel International: Large global CRO with significant commercial and market access services. Overlaps with OrchidPharmed's clinical research and commercial offering, though with a much broader geographic and therapeutic footprint.
Emerging players
- Publicis Health: Healthcare-focused marketing and communications network within Publicis Groupe. Comparable in the pharma marketing and HCP engagement layer, though less focused on field sales and patient support than OrchidPharmed.
Regional players
- Tata Strategic Pharma Group (TPGS): Tata group pharma services and strategic consulting arm operating in India and emerging markets. Comparable emerging-market-focused pharma services and commercial strategy model, though anchored in a different geography than OrchidPharmed's Iran operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Orchid Pharmed social profiles
Digital presenceOrchid Pharmed financial estimates
Financial estimateRevenue estimate
Valuation estimate
Orchid Pharmed leadership team
Management profileNumber of profiles
Orchid Pharmed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Orchid Pharmed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Orchid Pharmed
What does Orchid Pharmed do?
Orchid Pharmed is a pharmaceutical marketing and services company that commercializes biologic drugs and pharmaceutical products on behalf of partner manufacturers in Iran. It provides contracted marketing, sales, branding, supply chain, and market access services, runs clinical trials and pharmacovigilance programs, and operates the OrchidLife patient support division with 24/7 assistance and medication training centers in 60+ cities.
Is Orchid Pharmed a public or private company?
Orchid Pharmed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Orchid Pharmed founded?
Orchid Pharmed was founded in 2014. It employs 501 to 1,000 people.
Where is Orchid Pharmed based?
Orchid Pharmed is headquartered in Tehran, Iran, in the Middle East region.
How does Orchid Pharmed make money?
Three revenue lines are on record. Pharmaceutical Product Marketing is the primary driver. The others are clinical Research Services and patient Support Services.
Who are Orchid Pharmed's main competitors?
Veeva Systems is listed as an others. Direct peers are IQVIA, CMIC Holdings, Inizio, Syneos Health and Apodi (Cencora). Broad incumbents are Charles River Laboratories and Parexel International. Publicis Health is listed as an emerging player. Tata Strategic Pharma Group (TPGS) is listed as a regional player.
Does Orchid Pharmed have an API?
No public API is recorded for Orchid Pharmed.
What industry is Orchid Pharmed in?
Orchid Pharmed's product category is Pharmaceutical Marketing Services. Its primary akta.pro industry code is CRAOAHAD, Specialty Pharmacy & Biologics Distribution, with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its SIC code is 5122.